Cloud DX, Sheridan expand remote monitoring
December 9, 2020
WATERLOO, Ont. – Cloud DX, a leading provider of virtual care and remote patient monitoring solutions, has announced new advances in its collaboration with the Sheridan Centre for Mobile Innovation. Together, the partners are working toward the ‘Clinic of the Future’, where doctors and nurses will use mixed reality technologies and advanced remote patient monitoring to deliver better care to patients.
The collaboration is funded through the Canada Foundation for Innovation (CFI) and is part of a $28 million research infrastructure support initiative announced on November 6, 2020 by the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development. The funding, which covers the urgent need for equipment for ongoing research related to COVID-19, will support 79 projects at 52 universities and research hospitals, colleges, polytechnics and Cégeps across Canada.
The proposed Cloud DX system, currently in development, integrates mixed reality on the Microsoft HoloLens to display real-time vital sign telemetry from the Vitaliti™ continuous vital sign monitor, including Sp02 (oxygen saturation), temperature, blood pressure, heart rate, respiration rate and even 3D images of body organs.
The holographic environment also displays data from hospital-based electronic health records such as lab test results, X-rays, CT/MRI imaging files, clinical notes, medications and allergies. Clinicians can interact with the holographic displays using gestures or voice commands.
Sheridan’s Mobile Innovation team and Cloud DX will also further enhance the company’s Vitaliti™ wearable monitoring platform and its remote patient monitoring (RPM) capabilities by adding electrocardiograph (ECG), photoplethysmograph (PPG), thermal, accelerometer, gyroscope and presence sensors.
“RPM offers two key value propositions during the ongoing COVID-19 pandemic. First, it paves the way for early discharge from the hospital. The sooner a patient can be safely sent home, the less the strain on the healthcare system, which directly equates to lower costs for hospitals and payers,” said Dr. Sonny Kohli (pictured), chief medical officer for Cloud DX.
He added, “Second, it allows for rapid intervention. Vital signs today are not measured continuously in most healthcare facilities or at home. Changes that signify deterioration may not be caught in time, and subtle trends indicating health changes may not be detected until an egregious impact occurs. This is particularly true for those recovering at home from COVID-19, where changes in condition can occur suddenly.”
“We are proud to be working with the visionary team at Cloud DX to develop technologies that will transform patient care for the better,” said Dr. Edward Sykes, director, Centre for Mobile Innovation.
For more information about Vitaliti please visit https://www.clouddx.com/#/vitaliti.
Join Cloud DX Chief Medical officer and ICU critical care physician Dr. Sonny Kohli as he visits a patient’s bedside in the hospital of the future aided by Vitaliti and the HoloLens: https://share.vidyard.com/watch/V3wjMdGbpVY2MUn6e2SY3D?
About Cloud DX
Cloud DX is a leader in digital healthcare with rapidly growing sales across North America. Our complete remote patient monitoring platform incorporates proprietary medical devices, mobile apps, clinical dashboards, artificial intelligence and EMR integration. In one recent third-party study, Cloud DX technology reduced hospital admissions due to COPD while achieving 100% patient satisfaction. The company is the co-winner of the Qualcomm Tricorder XPRIZE, a Fast Company “World Changing Idea” finalist and a winner of the Waterloo MedTech Startup to Scale Up Award of Excellence.